Cetirizine Hydrochloride
- Product NDC
- 70934-199
- 11-digit product format
- 709340199
- Labeler code
- 70934
- Product ID
- 70934-199_f1629845-7641-10b6-e053-2995a90ae98c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA077829
- Marketing category
- ANDA
- Marketing start
- 2018-12-04
- Marketing end
- 2024-09-30
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-199-30 | 70934019930 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-199-30) | 30 tablet | 2019-10-29 | 0000-00-00 | No | No | Current |
| 70934-199-90 | 70934019990 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-199-90) | 90 tablet | 2018-12-04 | 0000-00-00 | No | No | Current |
| 70934-199-97 | 70934019997 | 100 TABLET in 1 BOTTLE, PLASTIC (70934-199-97) | 100 tablet | 2019-10-29 | 0000-00-00 | No | No | Current |